Kamada (KMDA) Director Uri Botzer Receives Stock Award

What Happened

• Director Uri Botzer received two option awards on August 27, 2026, each covering 30,000 ordinary shares (total 60,000) reported as derivative grants with an acquisition price of $0.00. These are equity award grants under the Company's plan, not open-market purchases or sales.

Key Details

• Transaction date: 2026-08-27 (reported on Form 4 filed 2026-09-29).
• Grant size: 2 awards × 30,000 options = 60,000 options total; reported acquisition price $0.00 (derivative).
• Exercise prices: previously reported at $5.39 and $7.42; both were adjusted in connection with the Company’s special cash dividend declared Aug 17, 2026 (record date Aug 27, 2026). Reported USD exercise prices reflect NIS→USD conversion per Bank of Israel rate as of Sept 29, 2026 (see footnote).
• Vesting and term: Options vest 25% annually over four years and are exercisable for 10 years from grant (per footnote).
• Holding: Awards are held by a trustee under the Company’s 2011 Share Award Plan.
• Shares owned after transaction: not specified in the filing.
• Timeliness: Form 4 was filed on 2026-09-29 for an 2026-08-27 grant — this appears to be a late filing (filed more than the typical two business days after the transaction).

Context

• These are grants of options/awards (derivative instruments), not immediate purchases or sales; no shares were sold as part of this filing. The awards will vest over time and require exercise (at the applicable exercise prices) to convert into ordinary shares. Adjustments to exercise prices reflect the company’s special cash dividend rather than a change in the award’s economics by the insider.